Randomized Controlled Trial to Improve Self-Efficacy in People With Multiple Sclerosis: The Community Reintegration for Socially Isolated Patients (CRISP) Program

The American Journal of Occupational Therapy : Official Publication of the American Occupational Therapy Association
J Tamar KalinaYael Goverover

Abstract

We examined the efficacy of a 12-wk educational socialization program, Community Reintegration for Socially Isolated Patients (CRISP), in improving self-efficacy for people with multiple sclerosis (MS). We also examined whether participants in the experimental group with increased self-efficacy experienced reduced loneliness and depression. This randomized controlled group design included 91 participants with MS (experimental group, n = 51; control group, n = 40). Participants were between ages 20 and 68 yr, and the majority experienced a relapsing-remitting MS course (86%) and mild to moderate disability. Participants completed baseline and posttreatment assessments, including questionnaires assessing self-efficacy, loneliness, and depression. Experimental group participants significantly improved in self-efficacy compared with control group participants. Experimental group participants who demonstrated improved self-efficacy reported reduced perceptions of loneliness but not depressive symptoms. CRISP is a promising intervention to improve self-efficacy for people with MS. However, results need to be treated with caution given the study's limitations.

References

Jan 1, 1986·International Journal of Rehabilitation Research. Internationale Zeitschrift Für Rehabilitationsforschung. Revue Internationale De Recherches De Réadaptation·A B KornblithH M Baum
Feb 1, 1996·Journal of Personality Assessment·D W Russell
Jul 1, 1997·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Z M ShnekJ Irvine
Aug 11, 1998·Journal of Personality Assessment·D L NyenhuisD C Garron
Oct 12, 1999·Multiple Sclerosis : Clinical and Laboratory Research·M J HoholH L Weiner
Apr 16, 2003·International Journal of Aging & Human Development·Prem S Fry, Dominique L Debats
Apr 24, 2003·Multiple Sclerosis : Clinical and Laboratory Research·C-H ChangA T Reder
Feb 6, 2004·Multiple Sclerosis : Clinical and Laboratory Research·A RiaziJ C Hobart
Jul 27, 2007·Rehabilitation Nursing : the Official Journal of the Association of Rehabilitation Nurses·Claudia C Beal, Alexa Stuifbergen
Sep 12, 2007·British Journal of Health Psychology·S A RigbyC A Young
Sep 4, 2008·Journal of the International Neuropsychological Society : JINS·Peter A ArnettJoe E Beeney
Mar 10, 2011·Annals of Neurology·Chris H PolmanJerry S Wolinsky
Mar 10, 2012·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Robert W MotlYoojin Suh
Apr 5, 2012·The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences·Sean P MullenThomas R Prohaska
May 12, 2012·Archives of Physical Medicine and Rehabilitation·Dagmar AmtmannJo Ann Brockway
Sep 26, 2012·Disability and Rehabilitation·Alexander NgDeborah Miller
Oct 11, 2012·Disability and Rehabilitation·A C Garfield, N B Lincoln
Dec 11, 2013·Rehabilitation Psychology·Margaret M SchmittNancy Chiaravalloti

❮ Previous
Next ❯

Citations

Oct 15, 2018·The Cochrane Database of Systematic Reviews·Sascha KöpkeAndrea Giordano
Jul 10, 2020·Scandinavian Journal of Occupational Therapy·Éle Quinn, Sinéad M Hynes
Feb 7, 2021·International Journal of Environmental Research and Public Health·Luis De-Bernardi-OjuelManuela García-de-la-Hera

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.